Project Grant R01CA315494
Award Date 7/20/26
Completion Date 6/30/31
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Edison, NJ 08837, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $345,413 to the University of Rochester on June 10, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to support a randomized clinical trial designed to increase lung cancer screening (LCS) uptake among high-risk emergency department (ED) patients. The research addresses a critical gap in cancer prevention, as fewer than one in six eligible individuals currently undergo LCS despite...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Icahn School of Medicine at Mount Sinai a $711,272 Project Grant under the Cancer Treatment Research program (CFDA 93.395) effective July 1, 2026, through June 30, 2031, to develop and evaluate improved lung cancer screening (LCS) approaches for people living with HIV (PWH). The research will focus on identifying optimal screening strategies by developing HIV-specific lung cancer risk prediction models to replace current...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $2.99 million Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded on September 23, 2025, with a completion date of August 31, 2029. This grant funds research to characterize lung cancer screening (LCS) trends and outcomes among people with HIV (PWH) in the United States, addressing a significant gap in empirical...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $425,088 Project Grant to The Washington University Office of Sponsored Research Services, effective May 1, 2026, through April 30, 2031, under the Cancer Cause and Prevention Research program (CFDA 93.393). This research project will deliver a comprehensive comparative analysis of lung cancer care delivery and patient outcomes across two distinct Medicare enrollment pathways: Traditional Medicare (fee-for-service) and...
- Federal Grant Award Summary Fred Hutchinson Cancer Center received a $714,192 Project Grant from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394), awarded June 1, 2026, with completion scheduled for May 31, 2031. The project delivers a novel lung cancer subtype-specific risk stratification approach designed to address critical limitations in current low-dose computed tomography (CT) screening protocols. The research combines detection of...
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences (RBHS)-School of Nursing received a $403,689 Project Grant award from the National Cancer Institute (NCI) effective August 1, 2025, through July 31, 2027, under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant funds research investigating the influence of menthol cigarette smoking on lung cancer screening eligibility within a national prospective cohort study....
- Federal Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $429,399 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period September 1, 2025 through August 31, 2027. The award supports the recalibration of the Lung Cancer Policy Model (LCPM) to address critical limitations in how the model estimates the effectiveness and cost-effectiveness of low-dose computed tomography...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Oklahoma Health Sciences Center a $424,480 Project Grant on September 11, 2025, under the Cancer Treatment Research program (CFDA 93.395). The four-year award, extending through August 31, 2029, supports research activities aimed at promoting Lead Academic Participating Sites (LAPS) studies accrual and lung cancer screening in Oklahoma. The grant funds the principal investigator's continued engagement with the...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a $635,340 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) on May 4, 2026, with a completion date of April 30, 2031. This award funds a research initiative titled "Functional Genomic Dissection of Lung Cancer In Vivo," which aims to identify and characterize tumor suppressor genes and their roles in lung cancer development. The project...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $695,154 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded July 1, 2026, with completion targeted for June 30, 2031. The grant funds research investigating inter-individual phenotypes of cancer gene mutation susceptibility in the human airway, with performance conducted in Bronx, New York. The project will employ single-molecule mutation...